277) hypercoagulability did not resolve during treatment or for up to 1 month following a |
278) dosing, safety monitoring, and during of treatment or long-term outcomes for propra |
279) roup of children to assess their need for treatment or other psychosocial interventi |
280) nor disagreements, which would not affect treatment or prognosis, were present in 21 |
281) disagreements, which would affect either treatment or prognosis, were present in 37 |
282) Furthermore, randomness of treatment allocation could be significantl |
283) ariate are prevented with a small cost in treatment allocation randomness. |
284) ous types, and preserve the randomness of treatment allocation. |
285) Minimization lacks the randomness of treatment allocation. |
286) alysis, refugees had greater odds of LTBI treatment completion (Adjusted Odds Ratio |
287) Overall, LTBI treatment completion remains suboptimal. |
288) At BCHD-TB, LTBI treatment completion was significantly hig |
289) , and to identify factors associated with treatment completion. |
290) imum efficiency (maximum variance) of the treatment effect estimator. |
291) three degrees of freedom score tests for treatment effect in the TED and give formu |
292) or rate and power for hypothesis test for treatment effect on continuous outcomes ar |
293) and Health Survey to estimate the average treatment effect on the treated, it is fou |
294) s developing severe adverse effects under treatment showed significantly lower basal |
295) l predictions of the osteochondral defect treatment showed that the shear stress at |
296) Short and long-term bendiocarb treatment showed the central vein thickene |
297) Different methods of treatment showed varied success but none i |
298) r content after extraction and after each treatment were collected for microbial pro |
299) cs and one dog naïve to chemotherapeutic treatment were enrolled. |
300) ents who did not receive any preoperative treatment were retrospectively analyzed. |
301) six participants, currently in treatment, were interviewed. |
302) nique that assumed a detectable effect of treatment as a 50% reduction in the baseli |
303) ents of group A, in addition to the basic treatment as described earlier, received a |
304) vided into 11 groups according to surface treatments as follows: one control group ( |
305) 8 ± 0.71, p > 0.05) after 28 days treatment by GT. |
306) radiotherapy could be exploited in tumor treatment by developing combined radiother |
307) Its treatment by indirect reduction through us |
308) 27.5% for cumulative pregnancy rate after treatment cycle 1 to 3 and second service |
309) alan and prednisone) protocol on a 28-day treatment cycle. |
|